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1. Introduction 
Type 1, or insulin-dependent diabetes results from the destruction of insulin-producing -
cells in the pancreas. It typically occurs in previously healthy children, being one of the most 
common childhood diseases in modern time. Intriguingly, the diabetes morbidity continues 
to rise in most parts of the world, but the causes of this development remain elusive (the 
Diabetes Mondial (DIAMOND) Project Group, 2006).  
Many of the patients with type 1 diabetes may develop particularly in adult life severe 
complications encompassing both the microvascular (retinopathy, nephropathy, and 
neuropathy) and macrovascular (myocardial infarction, stroke and peripheral artery 
disease) system. The main underlying mechanism in the large vessels is represented by 
accelerated atherosclerosis with subsequent narrowing of the vessels and potential risk for 
plaque rupture. In smaller, as in the large vessels, severely impaired function of the inner 
layer (so-called endothelium) has been detected, and correlated with the risk of developing 
vascular complications, suggesting it to play a major role in precipitating the vascular 
disease.  
It is now well established that this widespread vasculopathy develop many years before the 
onset of vascular complications, perhaps even before the outbreak of diabetic 
hyperglycemia. What exactly drives this process remains speculative, but increasing 
evidence suggest that factors thought to trigger type 1 diabetes may as well be harmful for 
the vessels. Furthermore, as delineated below, the microvascular network surrounding the 
islets in the pancreas appears to have important contribution to the injury process that 
ultimately leads to type 1 diabetes. Further multidisciplinary efforts are warranted in order 
to better understand the mechanism of this disease and its complications. 
2. Epidemiology and pathogenesis of type 1 diabetes 
There is a widespread global variation in the incidence and prevalence of type 1 diabetes. In 
a report by Karvonen et al. from 2000, age-adjusted incidences ranged from a low of 
<1/100,000 per year in China and South America to a high of >20/100,000 per year in 
Sardinia, Finland, Sweden, Norway, Portugal, the United Kingdom, Canada, and New 
Zeeland. The incidence increased with age in most of the populations with the highest 
incidence observed in children 10-14 years of age. An updated report from 2006 (the 
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DIAMOND Project Group, 2006) showed trends of increased incidence annually across the 
world in the populations studied (4.0% in Asia, 3.2% in Europe, and 5.3% in North America) 
with the exception of Central America and the West Indies were the trend was a decrease of 
3.6%. The rate of increase in incidence cannot be explained by genetic shift in such a short 
period of time. An increasing burden of environmental factors, probably along with 
increased immune-mediated sensitivity of pancreatic cells to gene-environment interaction, 
could account at least in part for the rising prevalence of type 1 diabetes.  
Traditionally, interplay between genetic susceptibility and environmental factors is thought 
to provide the fundamental element for the disease. The major genetic susceptibility for 
developing type 1 diabetes is located on the human leukocyte antigen (HLA)-DQ region on 
chromosome 6. Two HLA-DQ haplotypes, DQA10301-DQB10302 (DQ8) and DQA10501-
DQB10201 (DQ2) are associated with high risk for developing diabetes. Almost 90% of 
patients with type 1 diabetes have at least one of these two haplotypes, compared to 20% of 
the general population (Redondo et al., 2001). These susceptibility genes are important 
regulators of the immune response; the molecules they encode reside on the cell surface and 
have the ability to process and present antigens to autoreactive T-cells.  
In genetically susceptible individuals there is a pathological presentation of autoantigens on 
the cell surface of the pancreatic islet cells. This, in combination with a failing negative 
selection of the T-cells in the thymus and decreased regulatory capacity of regulatory T-cells 
in peripheral blood (Lindley et al., 2005), leads to an inflammatory response within the 
pancreatic islets as well as to the production of antibodies against -cell antigens. Islet cell 
antibodies were the first ones described, but we now also recognize autoantibodies to 
insulin, glutamic acid decarboxylase and protein tyrosine phosphatase. Up to 90% of the 
patients with new onset type 1 diabetes have autoantibodies directed against one or more of 
these autoantigens It is yet to prove if the autoantibodies have an active role in the 
pathogenesis of type 1 diabetes but the presence and persistency of autoantibodies appear to 
increase the likelihood of developing type 1 diabetes. The inflammatory response leads to 
destruction of the pancreatic -cells and progressive loss of insulin secretion until reaching 
critically low levels or even complete insulin deficiency.  
3. Vascular endothelium in type 1 diabetes 
In children with diabetes risk HLA, signs of systemic endothelial cell activation can be seen 
already before the clinical onset of diabetes (Toivonen et al, 2004), suggesting it to be an 
early event in the disease process. Postmortem studies near the onset of type 1 diabetes have 
shown that class II HLA molecules may be abundantly expressed on vascular endothelial 
cells lining the capillaries and capillary sinusoids in the islets (Itoh et al., 1993). The 
upregulation of HLA is paralleled by strong expression of adhesion molecules (i.e. ICAM-1) 
in the same endothelial areas (Hanninen et al., 1992).  These events, seemingly induced by 
circulating proinflammatory mediators, facilitate homing and migration of inflammatory 
cells such as T cells across the dysfunctional endothelium . Interaction between antigen-
specific T-cells and antigen/HLA complexes on the endothelial cells surface induced a rapid 
transmigration of the T-cells across the endothelial cell layer (Greening et al., 2003). Similar 
changes may be found on the surface of endothelial cells of other vascular beds (Greening et 
al., 2003).This fits well with the clinical observation that type 1 diabetes is often comorbid 
with chronic autoimmune diseases in other organs such as gut (celiac disease) and thyroid 
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gland (autoimmune thyroiditis). These disorders also share some of the HLA DQ diabetes 
risk alleles. An activated endothelium could be the link.  
It is well known that long-term exposure to hyperglycemia, hyperlipidemia and 
inflammation, all of which being important features of type 1 diabetes, is harmful to the 
endothelial cells, causing further endothelial dysfunction, and in the long run, accelerated 
atherosclerosis. Lymphocyte accumulation within the arterial wall is an important 
mechanistic component in the atherosclerotic process and contributes to endothelial cell 
injury and dysfunction. The endothelial injury, in turn, promotes additional immune events, 
including release of different chemokines and cytokines resulting in further transmigration 
of immune cells, and synthesis of C-reactive protein via liver activation by interleukin-6.  
Recent study, assessing the relationship of genetic susceptibility with endothelial 
dysfunction in young patients with type 1 diabetes, found significant correlation between 
HLA-DQ 2/8, which confers the highest risk for developing type 1 diabetes, and cutaneous 
microvascular dysfunction (Odermarsky et al., 2007). This could imply, although its does 
not prove, a role for HLA in the pathogenesis of type 1 diabetes. Further studies at our 
center are under way to investigate whether such changes could be present already before 
the clinical onset of type 1 diabetes.   
4. Exogenous risk factors and type 1 diabetes: Is vascular endothelium a 
link? 
Putative environmental triggers include viruses, environmental toxins and foods, but it has 
been difficult to demonstrate a reproducible correlation between them and the development 
of type 1 diabetes (The environmental determinants of diabetes in the young (TEDDY) 
Study Group, 2008). Although appealing, there is no evidence to date of a direct interplay 
between infections and genetics in the causation of type 1 diabetes. the risk of developing 
T1D seems to increase with the number of infections experienced by an individual during 
the year preceding the onset of T1D. Although we currently lack the knowledge of the 
precise underlying mechanisms, there are other reports on similar associations between 
infectious recurrence and chronic diseases such as multiple sclerosis or rheumatoid arthritis. 
In some animal studies, the development of atherosclerotic plaque was accelerated by 
repeated infection. One possible mechanistic link between these chronic inflammatory 
diseases (e.g. atherosclerosis and T1D) and infection might be endothelial injury. Infections 
cause vascular endothelial dysfunction, which may persist for up to 1 year after the 
infectious illness. Mild respiratory infections (“common cold”) seem to aggravate arterial 
endothelial dysfunction in young patients with T1D. Those with increased recurrence of 
infections of this type are more susceptible to decreased carotid artery elasticity. The latter 
was earlier shown to be in part dependent on the functional integrity of endothelial cells. In 
atherosclerosis-susceptible mice, the degree of endothelial vasomotor dysfunction in skin 
microcirculation correlates with the number of pathogen inoculations (Odermarsky M, 
Liuba P unpublished data). 
It has been shown that even mild viral infection causes vascular endothelial dysfunction, 
which may persist for up to 1 year after the infectious illness (Charakida et al., 2005). 
Infections promote the inflammatory environment needed for endothelial cell activation and 
upregulation of HLA. These changes could, if genetic susceptibility is present, contribute to 
homing, transmigration, and accumulation of inflammatory cells in certain tissues. In the 
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pancreas these microcirculatory changes could perhaps have a role in the pathogenesis of 
type 1 diabetes, but this is still hypothetical. 
5. Endothelial function and dysfunction 
The endothelial cells line the inner surface of all blood vessels, providing a metabolically 
active interface between blood and tissue. These cells modulate blood flow, nutrient 
delivery, coagulation and thrombosis, and leukocyte diapedesis. The endothelium 
synthesizes important bioactive substances. Of these, nitric oxide is the most potent 
vasodilator and protector of vascular function, inhibiting platelet activation and 
aggregation, preventing leukocyte adhesion and migration through the vessel wall, 
diminishing smooth muscle cell proliferation and migration, and counteracting adhesion 
molecule expression (Beckman et al., 2002). Nitric oxide is synthezised by the endothelial 
isoform of nitric oxide synthase. The process involves enzymatic conversion of L-arginine 
into nitric oxide and L-citrulline. The release of nitric oxide can be up- or downregulated by 
different factors. The hormone estrogen, physical exercise, and certain dietary factors are 
examples of upregulators, whereas smoking and oxidized low-density lipoproteins, via 
oxidative stress, are examples of downregulators (Michel & Vanhoutte, 2010). 
Endothelial dysfunction is considered to be the first step in a long-lasting and complex 
development that leads to atherosclerosis. The dysfunction is a result of an imbalance in the 
redox-equilibrium towards oxidative stress leading to impaired nitric oxide bioavailability, 
either caused by its reduced synthesis or by increased breakdown via reactive oxygen 
species. (Versari et al., 2009). The dysfunctioning endothelium may produce other 
substances and mediators such as endothelin 1, thromboxane A2, prostaglandin H and 
reactive oxygen species, with vasoconstricting, pro-inflammatory, and proatherosclerotic 
effects (Virdis et al., 2010). 
Given the excess of inflammatory and oxidative stress in type 1 diabetes, the endothelium in 
individuals with type 1 diabetes is continually exposed to factors promoting the 
development of endothelial dysfunction. The hyperglycemia, excess free fatty acid release, 
and insulin resistance leads to adverse events within the endothelial cell (Beckman et al., 
2002). Recent findings support the concept that genetically susceptible individuals, i.e. 
diabetes high-risk HLA, are more prone to develop endothelial dysfunction (Odermarsky et 
al., 2007) and ongoing studies are investigating whether this dysfunction in fact may 
precede the clinical onset of type 1 diabetes.  
The generalized microvascular dysfunction in type 1 diabetes is an important mechanism in 
the development of these microvascular complications. Nephropathy, retinopathy and 
neuropathy are all related to damage to the small vessels of the kidney, retina and nerves. 
Significant associations have been reported between the different microvascular complications 
of type 1 diabetes; patients with one complication often develops a second one, suggesting 
common risk factors and pathogenetic mechanisms (Girach & Vignati, 2006).  
Overt microvascular disease is however rare during childhood and adolescence. Early signs, 
such as increases in albumin excretion rates and glomerular filtration rates, renal 
hypertrophy, changes in retinal microvasculature and impaired autonomic nervous system 
function may be detectable in kids with type 1 diabetes and often progress during puberty. 
Microalbuminuria is the earliest stage of clinical nephropathy and is predictive of 
progression to overt diabetes nephropathy and, notably, of cardiovascular disease (Rossing 
et al., 1996).  
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6. Methods for evaluating endothelial function 
The ability to detect endothelial dysfunction, before it progresses to overt vasculopathy, 
could facilitate the early diagnosis and management of high-risk individuals in childhood. 
There are several techniques that can be used, though they are not in clinical use to any 
higher extent. Here we will present two methods; flow-mediated dilatation and laser 
doppler flowmetry with iontophoresis, which are the ones used in our research.  
6.1 Assessment of arterial dysfunction via flow-mediated dilatation of the brachial 
artery  
Blood vessels respond to an increase in blood flow, or more precisely shear stress, by 
dilating. This phenomenon is called flow-mediated dilatation. The principal mediator for 
this is endothelium-derived nitric oxide. Assessment of flow-mediated dilatation of the 
brachial artery safely and non-invasively provides a measure of the systemic endothelial 
function. The brachial artery response to increased shear stress has been shown to correlate 
significantly with invasive testing of brachial (Irace et al., 2001) and coronary endothelial 
function (Andersson et al., 1995), as well as with the extent and severity of coronary 
atherosclerosis (Neunteufl et al., 1997), and carotid artery intima-media thickness (Gaeta et 
al., 2000).  
Several factors affect the response to the increase in shear stress, including temperature, 
food, drugs and sympathetic stimuli, female hormonal status, among others, and when 
conducting a study using this technique you must take these confounding factors into 
consideration. Ultra sound systems used must be equipped with software for two-
dimensional imaging, colour and spectral Doppler, an internal electrocardiogram monitor 
and a high-frequency vascular transducer. A straight segment of the brachial artery above 
the antecubital fossa is imaged in the longitudinal plane with the ultrasound probe securely 
fixed using a stereotactic clamp. A blood pressure cuff is then placed on the forearm and 
inflated to supra-systolic pressure. After cuff release, reactive hyperaemia results and is 
quantified using Doppler. The arterial diameter is recorded at end diastole using 
electrocardiographic gating to determine the response of the brachial artery to increase in 
flow. The flow-mediated dilatation is expressed as a percentage change of the arterial 
diameter from the baseline vessel size (Corretti et al., 2002; Thijssen et al., 2011). To control 
the smooth muscle cells ability to dilate the vessel, independently of the endothelium, and to 
determine maximum obtainable vasodilatation a dose of nitro-glycerine is administrated via 
spray or sublingual tablet.  
6.2 Assessment of microvascular dysfunction via laser doppler flowmetry with 
iontophoresis in the skin  
Iontophoresis is a non-invasive method of introducing charged substances across the surface 
of the skin by means of a small electric charge. The basic principle is that molecules of drugs 
in a solution that are positively or negatively charged will migrate across the skin under 
influence of an applied current according to the rule that like charges repel each other. The 
amount of drug delivered is dependent on the magnitude and duration of the current 
applied. The response in the skin vasculature is measured via a laser doppler device (Morris 
& Shore, 1996). The coherent light directed at the skin changes when it comes in contact with 
moving tissues (red blood cells) and the emerged light, i.e. skin perfusion, is measured by a 
photodiode.  
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Acetylcholine is the standard test drug for the assessment of endothelial function. The 
response to acetylcholine, using iontophoresis, correlates with diabetes duration and level of 
glycosylated haemoglobin (Khan et al., 2000). The mechanisms of acetylcholine-induced 
vasodilatation via ionphoresis remain debatable. In humans, nitric oxide appears to be the 
main mediator, but other endothelium-dependent vasodilators may contribute as well 
(Turner et al., 2008).  
Sodium nitroprusside is a nitric oxide donor and acts directly, i.e. endothelium-
independent, as a control on the smooth muscle cells causing vasodilatation. Cathodal 
current is used for delivering sodium nitroprusside.  
The current for both substances is set to 100 A for 20 seconds. For each of the substances to 
be tested five consecutive and equal doses are applied to generate dose-response curves. 
Baseline perfusion and changes in response to the substance are expressed as area under the 
curve. 
7. The ”common soil” hypothesis-is this applicable in type 1 diabetes? 
In 1995, Michael Stern put forward the “common soil” hypothesis, which suggests a shared 
genetic and environmental origin for type 2 diabetes and atherosclerosis (Stern, 1995). 
According to this hypothesis, infections leading to chronic inflammation could pertain to the 
group of environmental etiological factors. Indeed, the risk of developing type 1  diabetes – 
a condition associated with significant morbidity in cardiovascular diseases in adult life – 
could rise during viral infections (Blom et al., 1991). Moreover, the risk for childhood 
diabetes seems to increase in accordance with a higher number of infections during the year 
preceding diagnosis. Studies in rodent models of atherosclerosis suggest similar dose-
dependent association between infection and vascular changes (Liuba et al., 2000; 
Tormakangas et al., 2005). Furthermore, diabetic patients are more vulnerable to viral 
infections due to defective lymphocyte-related immunity. In a previous cross-sectional 
study on diabetic children, we found that recurrent viral infections in the upper airways 
(“common cold”) during the past year had cumulative adverse effects on the elastic 
properties (i.e. compliance) of carotid arteries. In a multivariate analysis, the number of viral 
infections, along with age and plasma levels of glycosylated hemoglobin, significantly and 
independently predicted the decrease in carotid artery compliance (Odermarsky et al., 
2008a). Although impaired carotid elasticity is generally regarded as a marker of early 
atherosclerosis, these findings do not necessarily imply causality to accelerated 
atherosclerosis. Prospective studies in children are currently in progress.  
8. Prevention strategies in type 1 diabetes via vascular pathways? 
Should vascular endothelial dysfunction prove to play a pivotal role in the pathogenesis of 
both type 1 diabetes and its associated vascular disease, it is then conceivable that combined 
endothelium-targeting and immunoregulatory strategies already in diabetes-risk 
individuals without overt type 1 diabetes (i.e. diabetes high-risk HLA individuals) might 
reduce not only the cardiovascular burden but also the prevalence of type 1 diabetes later in 
life. Dietary supplementation with L-arginine (substrate for nitric oxide synthesis via nitric 
oxide synthase), or antioxidants, in order to improve nitric oxide bioactivity, could for 
instance be relatively simple, risk-free strategy with potential benefit on endothelial 
dysfunction. Further studies are needed to provide additional mechanistic insights into the 
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gene-environment interaction on vascular endothelium and the timing and role of 
endothelial dysfunction in the development of type 1 diabetes and associated cardiovascular 
disease.  
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